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Resident bacteria play an important role in initiating and perpetuating gastrointestinal inflammation. We
previously demonstrated that six commensal bacteria including Bacteroides vulgatus caused more aggressive
colitis and gastritis in HLA-B27 transgenic rats than did the other five bacteria without B. vulgatus. This study
compared the degree of gastrointestinal inflammation in gnotobiotic HLA-B27 transgenic rats monoassociated
with either B. vulgatus or Escherichia coli. Gnotobiotic transgenic rats raised in Trexler isolators were selectively
colonized with either B. vulgatus or E. coli. Control rats were either germfree or colonized with six common
commensal bacteria (Streptococcus faecium, E. coli, Streptococcus avium, Eubacterium contortum, Peptostreptococ-
cus productus, and B. vulgatus [DESEP-B]). After 1 month, all the rats were killed and tissues were prepared
for histologic and biochemical evaluation. Colitis induced by B. vulgatus monoassociation was almost equal to
that in DESEP-B-colonized rats and was significantly more severe than E. coli-induced colitis, which was
absent by histological testing and mild by colonic myeloperoxidase and interleukin-1b concentration deter-
minations. However, gastritis was detectable only in DESEP-B-associated rats. These studies suggest that not
all resident bacteria have equal proinflammatory capabilities, since B. vulgatus alone is more active than E. coli
alone in inducing colitis, and that colitis and gastritis result from different luminal bacterial stimuli.
Extensive recent data support the major influence of normal
resident bacteria on the initiation and perpetuation of intesti-
nal inflammation and extraintestinal manifestations in experi-
mental colitis and human inflammatory bowel disease (25–27).
Luminal bacteria have been implicated in the pathogenesis of
multiple experimental colitis models (1, 3, 7–9, 20–22, 28, 32,
36). However, not all bacteria have equal abilities to cause
inflammation, as demonstrated by their differential responses
to antibiotics with narrow specificities and colonization with
defined bacterial subsets. Metronidazole, which is selectively
active against anaerobic bacteria, is effective in Crohn’s colitis
and ileocolitis (31) and also attenuates chronic experimental
intestinal inflammation in the indomethacin- and carrageenan-
induced models (19, 36) and in HLA-B27 transgenic rats (23,
24). Anaerobic bacterial overgrowth in bypassed jejunoileal
segments created to treat morbid obesity leads to systemic
inflammation (6), and experimental small intestinal anaerobic
bacterial overgrowth through creation of a jejunal self-filling
blind loop can induce hepatobiliary inflammation and reacti-
vate quiescent arthritis in genetically susceptible Lewis rats
(15, 16). Similarly, experimental cecal anaerobic bacterial over-
growth potentates colitis in HLA-B27 transgenic rats (23). In
both human and rat small intestinal bacterial overgrowth mod-
els, broad-spectrum antibiotics or metronidazole can treat sys-
temic manifestations (10, 14, 23). These results from experi-
ments with multiple clinical and experimental conditions
suggest a dominant proinflammatory role for anaerobic com-
mensal bacteria.
Several resident bacteria have been associated with Crohn’s
disease, ulcerative colitis, and chronic inflammation in animal
models (26, 27). Luminal concentrations of Bacteroides (13),
Eubacterium, Peptostreptococcus, and Coprococcus (33) are in-
creased in Crohn’s patients, while facultative anaerobic bacte-
ria such as Streptococcus faecium (enterococcus, group D strep-
tococcus) are increased in patients with ulcerative colitis (26).
Serum antibodies to Eubacterium, Peptostreptococcus, and
Coprococcus are specifically increased in Crohn’s disease (2),
and functionally altered Escherichia coli has been implicated in
the pathogenesis of ulcerative colitis (26). Furthermore, lumi-
nal concentrations of E. coli and Enterococcus species correlate
with aggressiveness of colitis in B27 transgenic rats (21). Bac-
teroides vulgatus plays an essential role in the pathogenesis of
carrageenan-induced colitis in the guinea pig (20), and purified
cell wall polymers from Eubacterium, Peptostreptococcus, and
Streptococcus faecium can induce or reactivate quiescent ar-
thritis in genetically susceptible hosts (29, 30). Furthermore,
gnotobiotic B27 transgenic rats colonized with a mixture of six
different obligate and facultative anaerobic bacteria containing
Streptococcus faecium (group D), Streptococcus avium, Pep-
tostreptococcus productus, E. coli, Eubacterium contortum, and
B. vulgatus (DESEP-B) developed much more active colitis
and gastritis than did littermates colonized with the same mix-
ture without B. vulgatus (22).
These results suggest that B. vulgatus preferentially induces
colitis in B27 transgenic rats, but they do not conclusively
exclude an adjunctive or even necessary confunctional role for
the other five bacterial strains cocolonizing these gnotobiotic
rats. The aims of the present study are to compare the abilities
of two different common commensal enteric bacteria, B. vul-
gatus and E. coli, to induce colitis and gastritis in monoassoci-
ated HLA-B27 transgenic rats and to compare the inflammatory
effects of these single bacterial strains with those of the cocktail of
six bacteria previously investigated in this model (22).
MATERIALS AND METHODS
Experimental design. HLA-B27/b2-microglobulin (HLA-B27) transgenic rats
of the 33-3 line on an inbred F344 background (12) raised under germfree (GF)
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(sterile) conditions (22) were divided into four groups at the age of 2 months.
One group remained GF (n 5 10) and served as negative controls. The other
groups were transferred into separate isolators and then colonized with different
bacteria or bacterial cocktails by techniques described previously (22). One
group (n 5 11) was selectively colonized with B. vulgatus derived from a guinea
pig with carrageenan-induced colitis (a gift from A. B. Onderdonk, Harvard
University, Cambridge, Mass.). The second group (n 5 8) was monoassociated
with E. coli derived from a patient with active Crohn’s disease and provided by
the Clinical Microbiology Laboratory of the University of North Carolina Hos-
pitals, Chapel Hill, N.C. The third group (n 5 12) was colonized with a cocktail
of six bacteria (DESEP-B) with previously reported proinflammatory activity in
this model (22) and served as a positive control. These bacteria were isolated
from patients with Crohn’s disease (except for B. vulgatus) and included the B.
vulgatus and E. coli strains used for monoassociation of littermates. Persistent
selective bacterial colonization was documented by fecal Gram stain and culture
1 week after colonization and at necropsy. All the rats were clinically observed
for evidence of diarrhea and arthritis and were killed at 3 months of age (1 month
after colonization) by CO2 asphyxiation within 3 h of removal from the gnoto-
biotic isolators. The cecal tip and antrum of each rat were fixed in 10% neutral
buffered formaldehyde for histological processing. Right colonic segments were
taken and snap frozen in methyl-butane at 280°C for biochemical evaluations.
Histological testing. Tissues were fixed in 10% neutral buffered formaldehyde
for 4 to 12 h, transferred into 70% ethanol, and processed the next day by
standard techniques (22). Coded samples were examined under light microscopy
by a single observer (H. C. Rath). Cecal and gastric inflammation were quanti-
tated by a previously validated histological scoring system ranging from 0 to 41
(22).
MPO assay. Methods of tissue preparations and the assay of colonic myelo-
peroxidase (MPO) activity (units per gram of tissue) were described previously
(11).
Enzyme-linked immunosorbent assay. Interleukin-1b (IL-1b) protein concen-
trations in the cecal tissue were measured by a rat IL-1b enzyme-linked immu-
nosorbent assay developed by S. Poole (National Laboratory of Biological Stan-
dards and Controls, South Mimms, Potters Bar, Hertfordshire, United Kingdom)
(22).
Microbial analysis. Immediately after euthanasia, 1-ml samples from the cecal
contents of colonized nontransgenic rats were taken and serially diluted in
phosphate-buffered saline. Total bacterial concentrations were determined by
using counting chambers. Monoassociation was confirmed by Gram staining and
anaerobic culture.
Statistical analysis. All data are expressed as mean 6 standard error of the
mean SEM. To test for differences between the groups, analysis of variance was
used. Samples with equal distribution were compared by Student’s t test. P , 0.05
was considered statistically significant.
RESULTS
Cecal inflammation. There was no evidence of grossly de-
tectable inflammation in any group. Histologically, cecal in-
flammation of DESEP-B-colonized rats was characterized as
mononuclear cell infiltration limited to the lamina propria with
hypertrophy of the mucosa, crypt dilatation, and focal crypt
abscesses. Rats monoassociated with B. vulgatus had a similar
histologic pattern (Fig. 1B) and by blinded microscopic score
had almost as much cecal inflammation as did the positive
controls colonized with the six commensals, including B. vul-
gatus (1.7 6 0.2 and 2.1 6 0.1, respectively [P 5 0.06]) (Fig. 2).
Rats monoassociated with E. coli had almost no cecal inflam-
mation (Fig. 1A), and their histologic scores were nearly iden-
tical to those of GF animals (0.8 6 0.2 and 0.7 6 0.1, respectively
[not significant]) (Fig. 2). Transgenic rats monoassociated with
B. vulgatus had more severe cecal inflammation than did those
monoassociated with E. coli (P 5 0.001). Cecal MPO activity
confirmed the lack of difference between DESEP-B- and B.
vulgatus-colonized rats and the significantly increased inflam-
mation in both of these groups compared with that in E. coli-
monoassociated (P , 0.03) and GF (P , 0.0001) rats (Fig. 3).
However, in contrast to the lack of histologic inflammation in
E. coli-monoassociated rats, colonic MPO levels were signifi-
cantly increased in the E. coli group compared with GF con-
trols (6.5 6 1.0 and 1.1 6 0.8, respectively [P , 0.0001]). IL-1b
protein concentrations in the cecal tissue were not significantly
different among the gnotobiotic groups; the concentrations in
all groups were significantly elevated compared to those in GF
rats (DESEP-B rats, 34.8 6 4.3 ng/g of tissue; B. vulgatus rats,
37.6 6 3.3 ng/g; E. coli rats, 25.3 6 4.6 ng/g [P , 0.0005 with
respect to GF rats, which had 5.2 6 0.6 ng/g]; B. vulgatus versus
E. coli was not significant [P 5 0.06]). Total luminal bacterial
concentrations in the cecum were not different among the
groups (1.0 3 104 to 4.4 3 1011 bacteria/ml of cecal contents).
Gastritis. Mononuclear inflammation in the gastric antrum
is a prominent feature in specific-pathogen-free HLA-B27
transgenic rats, although it is absent in GF rats (22). As pre-
viously described, transgenic rats colonized with DESEP-B had
active antral mucosal inflammation (histological scores of
1.4 6 0.2 with respect to 0.6 6 0.1 for GF rats [P , 0.05]) (Fig.
2). However, transgenic rats monoassociated with either B.
vulgatus or E. coli had significantly less gastritis (0.8 6 0.2 and
0.7 6 0.2, respectively [P , 0.04] with respect to DESEP-B)
and were not different from GF rats.
DISCUSSION
In a recent study we demonstrated that six common intesti-
nal commensals isolated from patients or guinea pigs with
colitis, including B. vulgatus, could cause colitis and gastritis in
HLA-B27 transgenic rats (22). However, the same cocktail
minus B. vulgatus caused virtually no intestinal inflammation.
These data strongly incriminated B. vulgatus in the pathogen-
esis of colitis and gastritis in HLA-B27 transgenic rats. How-
ever, the question still remained whether this inflammation
was an effect of B. vulgatus alone or whether the other bacteria
in this cocktail had a synergistic or maybe even an antagonistic
influence. To address this question, we monoassociated GF
transgenic rats with either B. vulgatus or E. coli, another com-
ponent of this cocktail. In the present study, we demonstrated
that B27 transgenic rats monoassociated with B. vulgatus de-
veloped colitis comparable to that in rats colonized with the six
commensal bacteria but that E. coli-monoassociated rats had
no histological evidence of colitis although slight increases in
MPO and IL-1b concentrations in tissue were noted. Differ-
ential abilities to induce colitis were not due to colonization
efficiency, since colonic luminal concentrations of B. vulgatus
and E. coli were almost identical. These observations are con-
sistent with a series of results from our group as well as from
other investigators. Onderdonk et al. demonstrated in complex
repopulation and monoassociation studies that B. vulgatus was
the dominant stimulus in carrageenan-induced colitis in guinea
pigs (20), and Dianda et al. showed that T-cell receptor alpha
(TCRa)-deficient mice monoassociated with E. coli or Strep-
tococcus faecium had no colitis (9). Moreover, the therapeutic
efficacy of metronidazole in Crohn’s disease correlates well
with the degree of suppression of fecal Bacteroides concentra-
tions (13). Lichtman et al. showed that chronic metronidazole
therapy, which eliminated Bacteroides spp. without significantly
altering total luminal bacterial concentrations, prevented
hepatobiliary inflammation and reactivation of arthritis in rats
with jejunal self-filling blind loops (14, 16). We recently re-
ported that creation of a cecal self-filling blind loop in B27
transgenic rats was associated with 50-fold increased luminal
concentrations of Bacteroides species and potentiation of cecal
inflammation (23). Metronidazole eliminated luminal Bacte-
roides and attenuated colitis in this model (23). Furthermore,
enterotoxin from certain B. fragilis strains enhances mucosal
permeability and epithelial internalization of enteric bacteria
(35), and Bacteroides strains stimulate transforming growth
factor b1 production and collagen deposition in the colonic
wall in decontaminated rats following 2,4,6-trinitrobenzenesul-
fonic acid (TNBS)-ethanol (18). Finally, Cong et al. (7) docu-
mented T-lymphocyte responses to B. vulgatus in C3H/HeJBir
mice with colitis. The lack of a significant difference between
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the cecal inflammation of rats monoassociated with B. vulgatus
and those colonized with DESEP-B indicates that none of the
other five bacterial species exert a protective influence, espe-
cially since there was a strong trend towards more inflamma-
tion in the commensal-colonized group. However, the fact that
rats raised in a specific-pathogen-free environment have more
severe cecal inflammation than those colonized with the cock-
tail of six defined commensal bacteria (22) suggests that B.
vulgatus is not the only resident enteric bacterial strain capable
of inducing and/or perpetuating colitis in this model. It is
possible that other strains not represented in our cocktail can
initiate disease or, alternatively, that B. vulgatus selectively
initiates colitis in this model but that once it is initiated, other
bacteria may play a role in perpetuating and potentiating
chronic intestinal inflammation. The concept of synergistic ac-
tivities of various resident luminal bacteria in chronic intestinal
inflammation is supported by our preliminary observations that
the broad-spectrum antibiotic combination of vancomycin and
imipenem is superior to metronidazole or ciprofloxacin alone
in preventing and treating experimental colitis in HLA-B27
transgenic rats (24). The complex interaction of various lumi-
nal bacterial species is further illustrated by the recent corre-
FIG. 1. Histological features of colons from gnotobiotic HLA-B27/b2-microglobulin transgenic rats monoassociated with B. vulgatus or E. coli for 1 month. (A)
Cecal histological section from a transgenic rat monoassociated with E. coli. There is almost no sign of inflammation. (B) Cecal tissue from a transgenic rat
monoassociated with B. vulgatus. There is mononuclear cell infiltration of the lamina propria, mucosal thickening, crypt hyperplasia, and focal goblet cell depletion.
Magnification, 340.
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lation of cecal concentrations of E. coli and to a lesser extent
Enterococcus species with the degree of colitis in B27 trans-
genic rats (21). Although the concentrations of anaerobes,
including Bacteroides species, were not increased in rats with
severe colitis in the study by Onderdonk et al. (21), Bacteroides
was one of the most prevalent organisms (109 CFU/g of cecal
contents).
Neither of the two groups of monoassociated rats showed
any significant gastritis, whereas transgenic rats colonized with
DESEP-B manifested chronic antral inflammation. In our pre-
vious study of transgenic rats colonized with these commensals
excluding B. vulgatus, there was no significant colitis or gastritis
(22). In another experiment, HLA-B27 transgenic rats in a
specific-pathogen-free environment did not develop colitis or
gastritis if the cecum was excluded from the fecal stream, which
caused a consequent decrease of cecal bacterial concentrations
of about 2 log units (23), even though the bacterial concentra-
tion and composition in the gastric lumen did not change.
These results correspond to attenuation of distal colitis in
TCRa-deficient mice following excision of the cecal tip (“ap-
pendectomy”) (17). We hypothesize that the concentration
and composition of cecal bacteria are important not only in
inducing local colitis but also in stimulating remote inflamma-
tion, including the stomach. Cecal luminal bacteria prime lym-
FIG. 2. Blinded histological inflammatory scores of the cecum and antrum in gnotobiotic HLA-B27 transgenic rats. GF transgenic rats, 2 months old, were colonized
with DESEP-B, B. vulgatus alone, or E. coli alone or kept GF (negative control). The rats were killed 1 month after bacterial colonization. p, P 5 0.001 with respect
to E. coli and GF rats. §, P , 0.05 with respect to all three other groups.
FIG. 3. As a marker of neutrophilic infiltration, colonic MPO activity was increased in all colonized rats with respect to GF controls. Homogenized cecal tissues
collected 1 month after bacterial colonization were assayed by a colorimetric biochemical assay for MPO (see Materials and Methods). p, P , 0.03 with respect to E.
coli and P , 0.0001 with respect to GF rats. §, P , 0.0001 with respect to GF rats and P , 0.01 with respect to DESEP-B.
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phocytes in the extensive lymphoid aggregates of the cecal tip,
and then these lymphocytes circulate systemically and home to
remote mucosal organs, where they are activated if they are
exposed to the same bacterial antigens present in the cecum.
This hypothesis would explain (i) the lack of gastritis in rats
monoassociated with B. vulgatus, since this obligate anaerobe is
not present in high concentrations in the partially aerobic
stomach; (ii) the lack of gastritis in rats monoassociated with E.
coli, since E. coli does not initiate aggressive chronic inflam-
mation in the cecum; and (iii) the presence of gastritis in
DESEP-B-colonized rats, since B. vulgatus initiates the cecal
inflammation, which enhances the uptake of bacterial antigens
from facultative anaerobes present in the cecum as well as in
the stomach. This hypothesis is supported by the observation of
Aranda et al. that SCID mice raised in a specific-pathogen-free
environment develop colitis and gastritis after transfer of
CD45RBhigh cells but that “reduced-flora” SCID mice popu-
lated with three nonpathogenic Clostridium spp. fail to develop
colitis after cell transfer (1). It also explains the observations
that HLA-B27 transgenic nude rats raised in a specific-patho-
gen-free environment develop colitis and gastritis after transfer
of lymphocytes from transgenic euthymic rats with colitis (5)
whereas GF transgenic rats do not develop intestinal inflam-
mation after receiving the same T cells (24a). Although the
failure to transfer colitis to euthymic GF B27 transgenic recip-
ients could be due to resistance of euthymic recipients to colitis
mediated by transferred lymphocytes (4), we have shown in
preliminary studies that mesenteric lymph node cells from spe-
cific-pathogen-free CD3ε26 transgenic mice with colitis also do
not transfer disease to GF athymic recipients (34).
These results indicate that (i) resident luminal bacteria are
important in the initiation and perpetuation of chronic colitis
and gastritis in HLA-B27 transgenic rats, (ii) not all bacterial
strains have equal ability to cause gastrointestinal inflamma-
tion (some bacteria are more aggressive than others), and (iii)
different bacteria play different roles in the inflammatory pro-
cess (B. vulgatus plays a key role in initiating colitis in B27
transgenic rats, while other bacterial strains, although they
cannot initiate colitis, play an important role in mediating
inflammation in remote organs such as the stomach). These
observations have important therapeutic implications for de-
signing clinical trials investigating antibiotics with selective ac-
tivity in Crohn’s disease and ulcerative colitis.
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